Vanquish Oncology
Champaign
About Vanquish Oncology
Vanquish Oncology is a biotechnology company that develops targeted, small-molecule oncology therapeutics for unmet or underserved cancer markets. It features an advanced program in selectively triggering cancer cell death through activating procaspase 3, a key late-stage effector of apoptosis. The company was founded in 2011 and headquartered in Champaign, Illinois.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $6.4M
- Last round: Series Unknown (Jun 2019)
- Website: vanquishoncology.com
- Phone: 510-219-6200
Industries & Categories
Biotechnology, Life Science, Oncology, Therapeutics
Canonical: https://fsome.com/organization/vanquish-oncology-147206 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.